Miller; Todd Anthony

Patent Applications and Registrations

Patent applications and USPTO patent grants for Miller; Todd Anthony.The latest application filed is for "protective enclosures for portable electronic devices and related methods".

Company Profile

0.10.3

Miller; Todd Anthony - Tualatin OR
Miller; Todd Anthony - San Marcos CA
Miller; Todd Anthony - Bend OR
Miller; Todd Anthony - Union City CA
Miller; Todd Anthony - Encinitas CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Protective enclosures for portable electronic devices and related methods Grant 9,760,128 - Sande , et al. September 12, 2	2017-09-12
Protective Enclosures for Portable Electronic Devices and Related Methods App 20160291643 - Sande; Greg Mitchel ; et al.	2016-10-06
Pyrrole substituted 2-indolinone protein kinase inhibitors Grant 7,572,924 - Tang , et al. August 11, 2	2009-08-11
3-methylidenyl-2-indolinone modulators of protein kinase Grant 6,855,730 - Tang , et al. February 15, 2	2005-02-15
Indolinone compounds as kinase inhibitors Grant 6,689,806 - Tang , et al. February 10, 2	2004-02-10
3-methylidenyl-2-indolinone modulators of protein kinase App 20040024010 - Tang, Pen Cho ; et al.	2004-02-05
Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity Grant 6,642,251 - Tang , et al. November 4, 2	2003-11-04
Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity App 20030199510 - Tang, Peng Cho ; et al.	2003-10-23
3-Methylidenyl-2-indolinone modulators of protein kinase Grant 6,531,502 - Tang , et al. March 11, 2	2003-03-11
Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity Grant 6,525,072 - Tang , et al. February 25, 2	2003-02-25
Inhibitors of thrombosis Grant 5,955,576 - Vlasuk , et al. September 21, 1	1999-09-21
Arginine keto-amide enzyme inhibitors Grant 5,869,454 - Webb , et al. February 9, 1	1999-02-09
N-substituted glycine derivatives as enzyme inhibitors Grant 5,696,231 - Abelman , et al. December 9, 1	1997-12-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.